Status:
COMPLETED
NEWBIE Validate: Feasibility of a New Test to Measure Glucose in Newborn Blood Spots (NBS)
Lead Sponsor:
Royal Devon and Exeter NHS Foundation Trust
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Portsmouth Hospitals NHS Trust
Conditions:
Neonatal Diabetes
Eligibility:
All Genders
Brief Summary
The aim of this feasibility laboratory study is to evaluate whether the laboratory testing pathway for glucose screening in newborn blood spots (NBS) can be done at scale, and that the glucose test ha...
Eligibility Criteria
Inclusion
- Babies having a routine NBS screening test.
- Routine maternity care team within the area served by the Portsmouth regional screening laboratory (NHS Trusts within Hampshire, Dorset \& parts of Wiltshire)
Exclusion
- Parent decides to opt-out of the blood glucose test feasibility study.
Key Trial Info
Start Date :
July 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
10784 Patients enrolled
Trial Details
Trial ID
NCT04831723
Start Date
July 9 2021
End Date
June 30 2022
Last Update
May 6 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dorset County Hospital
Dorchester, United Kingdom
2
University Hospitals Dorset
Poole, United Kingdom
3
Portsmouth Hospitals NHS Trust
Portsmouth, United Kingdom
4
University Hospital Southampton
Southampton, United Kingdom